Asthma, adenosine, mast cells and theophylline

Clinical and Experimental Allergy, Supplement

Volumn 28, Issue 3, 1998, Pages 42-46

  Coward, W R ^a   Sagara, H ^a   Church, M K ^a  

^a SOUTHAMPTON GENERAL HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE; ADENOSINE RECEPTOR BLOCKING AGENT; CALCIUM ANTAGONIST; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 8; PHOSPHODIESTERASE INHIBITOR; THEOPHYLLINE; TUMOR NECROSIS FACTOR ALPHA;

ANTIINFLAMMATORY ACTIVITY; ARTICLE; ASTHMA; BRONCHODILATATION; CYTOKINE PRODUCTION; DRUG MECHANISM; ENZYME INHIBITION; HUMAN; MAST CELL; PRIORITY JOURNAL;

ADENOSINE; ANIMALS; ANTI-INFLAMMATORY AGENTS; ASTHMA; CYTOKINES; HUMANS; IMMUNOHISTOCHEMISTRY; LUNG; MAST CELLS; NF-KAPPA B; THEOPHYLLINE;

EID: 0031880713     PISSN: 09602178     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Fredholm BB, Persson CGA. Xanthine derivatives as adenosine antagonists. Eur J Pharmacol 1982; 81:673-6.
2. Mann JS, Renwick AG, Holgate ST. Release of adenosine and its metabolites from activated human leucocytes. Clin Sci 1986; 70:461-8.
3. Cushley MJ, Tattersfield AE, Holgate ST. Inhaled adenosine and guanosine on airway resistance in normal and asthmatic subjects. Br J Clin Pharmacol 1983; 15:161-5.
4. Mann JS, Holgate ST, Renwick AG, Cushley MJ. Airway effects of purine nucleosides and nucleotides and release with bronchial provocation in asthma. J Appl Physiol 1986; 61:1667-76.
5. Chan W, Cushley MJ, Holgate ST. The effect of adenosine 5′-monophosphate (AMP) on airway calibre in normal and asthmatic subjects [Abstract]. Clin Sci 1986; 70 (Suppl. 13):65P.
6. Turnheim K, Plank B, Kolassa N. Inhibition of adenosine uptake in human erythrocytes by adenosine-5′-carboxamides, xylosyladenine, dipyridamole, hexobendine and p-nitrobenzlythioguanosine. Biochem Pharmacol 1978; 27:2191-7.
7. Cushley MJ, Tallant N, Holgate ST. The effect of dipyridamole on histamine- and adenosine-induced bronchoconstriction in normal and asthmatic subjects. Eur J Respir Dis 1985; 67:185-92.
8. Cushley MJ, Tattersfield AE, Holgate ST. Adenosine induced bronchoconstriction in asthma: antagonism by inhaled theophylline. Am Rev Respir Dis 1984; 129:380-4.
9. Mann JS, Holgate ST. Specific antagonism of adenosine induced bronchoconstriction in asthma by oral theophylline. Br J Clin Pharmacol 1985; 19:685-92.
10. Venge P, Dahl R, Karlstrom R, Pedersen B, Peterson CB. Eosinophil and neutrophil activity in asthma in a one-year double- blind trial with theophylline and 2 doses of inhaled budesonide. J Allergy Clin Immunol 1992; 89:190.
11. Sullivan P, Bekir S, Jaffar Z, Page C, Jeffery P, Costello J. Antiinflammatory effects of low-dose oral theophylline in atonic asthma. Lancet 1994; 343:1006-8.
12. Jaffar ZH, Sullivan P, Page C. Low-dose theophylline modulates t-lymphocyte activation in allergen- challenged asthmatics. Eur Respir J 1996; 9:456-62.
13. Finnerty JP, Lee C, Wilson S, Madden J et al. Effects of theophylline on inflammatory cells and cytokines in asthmatic subjects - a placebo-controlled parallel-group study. Eur J Respir Dis 1996; 9:1672-7.
14. Burd PR, Rogers HW, Gordon JR et al. Interleukin-3 dependent and independent cell lines stimulated with IgE and antigen express multiple cytokines. J Exp Med 1989; 170:245-58.
15. Wodnar-Filipowicz A, Heusser CH, Moroni C. Production of the haemopoietic growth factors GM-CSF and interleukin-3 by mast cells in response to IgE receptor-mediated activation. Nature 1989; 11:150-2.
16. Plaut M, Pierce JH, Watson CJ et al. Mast cell lines produce lymphokines in response to cross linkage of FceRI or to calcium ionophores. Nature 1989; 339:64-7.
17. Selvan RS, Butterfield JH, Krangel MS. Expression of multiple chemokine genes by a human mast cell leukemia. J Biol Chem 1994; 269:13893-8.
18. Okayama Y, Semper A, Holgate ST, Church MK. Multiple cytokine mRNA expression in human mast cells stimulated via Fc epsilon RI. Int Arch Allergy Immunol 1995; 107:158-9.
19. Wershil BK, Wang ZS, Gordon JR, Galli SJ. Recruitment of neutrophils during IgE-dependent cutaneous late phase reactions in the mouse is mast cell-dependent. Partial inhibition of the reaction with antiserum against tumor necrosis factor-alpha. J Clin Invest 1991; 87:446-53.
20. Gordon JR, Post MJ, Schulman ES et al. Characterisation of mouse mast cell TNFa induction in vitro and in vivo and demonstration that purified human lung mast cells contain TNFa. [Abstract] FASEB J 1991; 5:A1009.
21. Shah A, Church MK, Holgate ST. Tumour necrosis factor alpha: a potential mediator of asthma. Clin Exp Allergy 1995; 25:1038-44.
22. Bradding P, Roberts JA, Britten KM et al. Interleukin-4, -5, and - 6 and tumor necrosis factor-alpha in normal and asthmatic airways: evidence for the human mast cell as a source of these cytokines. Am J Respir Cell Mol Biol 1994; 10:471-80.
23. Bradding P, Mediwake R, Feather IH et al. TNF-alpha is localized to nasal mucosal mast-cells and is released in acute allergic rhinitis. Clin Exp Allergy 1995; 25:406-15.
24. Okayama Y, Benyon RC, Rees PH et al. Inhibition profiles of sodium cromoglycate and nedocromil sodium on mediator release from mast cells of human skin, lung, tonsil, adenoid and intestine. Clin Exp Allergy 1992; 22:401-9.
25. Okayama Y, Hunt TC, Kassel O, Ashman LK, Church MK. Assessment of the anti-c-kit monoclonal antibody YB5.B8 in affinity magnetic enrichment of human lung mast cells. J Immunol Methods 1994; 169:153-61.
26. Vandal F, Kvalheim G, Lea TE et al Depletion of T lymphocytes from human bone marrow. Transplantation 1987; 43:366-71.
27. Walls AF, Bennett AR, McBride HM et al. Production and characterization of monoclonal antibodies specific for human mast cell tryptase. Clin Exp Allergy 1990; 20:581-9.
28. Coward WR, Sagara H, Holgate ST et al. NF-kB expression in dispersed human lung mast cells. [Abstract] Am J Respir Crit Care Med 1997; 155:A700.